ACTAR

Actar is a fully owned subsidiary to Karolinska Development. The company enables value building by early drug discovery efforts focused on innovative disease targets, to identify and validate low molecular weight lead compounds. Thus, Actar provides concept validation, research tools and data, to support future research and development activities within Karolinska Development. Projects are normally carried out as collaboration with cutting-edge academic research groups, providing invaluable knowledge and suitable biological test systems.

The Actar team includes project managers and specialists in drug discovery and development, covering disciplines such as biology, pharmacology, and medicinal chemistry. The team's experience comes from academic research as well as from biotech and pharma industry R&D operations.